EMBC · Embecta Corp.

Track EMBC — free

$5.10 -0.01 (-0.20%) At close · Aug 14

Market Cap

$288.96M

56.66M

Up next

Next earnings call

Nov 7, 2026 Est · unconfirmed · in 12 wks

FQ4-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Aug 7, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Ask ALVIS about this →

Equibles Rating

blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High

Market backdrop VIX 14.3 · calm Equity put/call 0.52

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg −39%

below

Price vs 50-day avg +46%

above

RSI (14) 74

overbought

MACD trend Positive

52-week position 18%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Weak

1-month return +57%

trailing

6-month return −52%

trailing

YTD return −57%

this year

Relative strength −66%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $4 › 200d $8 — 200d above 50d

Institutional flow Distributing

-8% holders QoQ · +64 funds added

Insider flow Accumulating

Net +$557.9K over 90 days · 0% sells

Short interest Rising

11.79% of float · ▲ +10.9% MoM · 5.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr low

314 holders — near 3-yr low, contrarian setup

Squeeze score 81

high risk · 0–100

Fundamentals

Strong

Revenue growth −4%

Y/Y

Gross margin 63%

contracting

EPS growth +21%

Y/Y

Free cash flow $182.4M

Valuation P/E 3.5

below peers

Buyback $100.0M

authorized

Balance sheet $1.2B

net debt

Quant / Vol

risk profile

Very High

Volatility 80%

annualized · 1-yr

Max drawdown −81%

past year

ATR 6.0%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Aug 7, 2026

Reported Revenues · fiscal year 2026 $1.02B – $1.04B

Adjusted Operating Margin · fiscal year 2026 Non-GAAP 23.5% – 24%

Adjusted Earnings per Diluted Share · fiscal year 2026 Non-GAAP $1.80 – $1.90

Prior guidance period ended · from the Earnings Call filed Mar 31, 2024

Revenue · full year 2024 $1.11B – $1.12B

Cash used towards separation activities · full year 2024 $180M – $190M

Constant currency revenue · full year 2024 -0.5% – 0%

Adjusted gross margin · full year 2024 64.5% – 65%

Adjusted earnings per share · full year 2024 $2.20 – $2.30

Adjusted operating margin · full year 2024 25.25% – 25.75%

Adjusted EBITDA margin · full year 2024 31% – 31.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral

2 · 3 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−39% Bearish

Price vs 50-day avg

+46% Bullish

RSI (14)

74 Bearish

MACD trend

Positive Bullish

52-week position

18% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bearish · 2 of 6

Trend (MA cross) No cross

50d $4 › 200d $8 — 200d above 50d

Institutional flow Distributing

-8% holders QoQ · +64 funds added

Insider flow Accumulating

Net +$557.9K over 90 days · 0% sells

Short interest Rising

11.79% of float · ▲ +10.9% MoM · 5.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr low

314 holders — near 3-yr low, contrarian setup

Price context

position in its 52-week range

Range low $3 Now $5 · 18% Range high $15

vs 200-day avg -39% vs 50-day avg +46%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted earnings per diluted share non-GAAP	$1.53	Nine months ended June 30, 2026	—

Adjusted EBITDA and margin non-GAAP	$247.5M	Nine months ended June 30, 2026	—

Adjusted EBITDA margin non-GAAP	32.8%	Nine months ended June 30, 2026	—

Adjusted Gross Profit non-GAAP	$158M	Three Months Ended June 30	—

Adjusted gross profit and margin non-GAAP	58.2%	Three months ended June 30, 2026	—
Adjusted Gross Profit Margin non-GAAP	58.2%	Three Months Ended June 30	—
Adjusted Net Income non-GAAP	$32.6M	Three Months Ended June 30	—

Adjusted net income and adjusted earnings per diluted share non-GAAP	$91M	Nine months ended June 30, 2026	—
Adjusted Operating Income non-GAAP	$69.4M	Three Months Ended June 30	—

Adjusted operating income and margin non-GAAP	25.5%	Three months ended June 30, 2026	—
Adjusted Operating Income Margin non-GAAP	25.5%	Three Months Ended June 30	—
Non-GAAP Free Cash Flow non-GAAP	$40.7M	Three Months Ended June 30	—
Adjusted gross margin non-GAAP	62.6%	Q1 FY2026	—
Adjusted operating margin non-GAAP	30.4%	Q1 FY2026	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Instruments & Supplies — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
EMBC Embecta Corp. this stock	$288.96M	-57.1%	-3.8%	3.5	11.8%
ISRG Intuitive Surgical Inc	$139.37B	-30.3%	+20.5%	45.3	1.9%
BDX Becton Dickinson & Co	$49.96B	—	+8.2%	—	3.7%
MDLN Medline Inc.	$46.99B	-14.9%	+11.5%	—	2.6%
ALC Alcon Inc	$35.89B	-5.8%	+10.5%	—	2.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

314

% held: 84.6%
Net QoQ: -12.9M sh
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

254

View

Short & Settlement

Short Interest Rising

Shares short

6.7M

Days to cover: 5.9d
Change: +655.7K sh

View

Short Volume

Short vol %

47%

As of: Aug 14, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $79
As of: Jun 30, 2026

View

Off-Exchange

Off-exchange %

34.3%

Week of: Jul 6, 2026

Off-exch Lit

View

Smart Money

Insider Trades Cluster buy

Net (90d)

+$557.9K

Buyers / Sellers: 4 / 0

Buyers Sellers

View

Financials

Revenue (FY)

$1.1B

Net income (FY): $95.4M
EPS diluted: $1.62

View

Buybacks

Authorized

$100.0M

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 7, 2026
This year: 10

View

Proposed Sales

Value

$50.8K

Shares: 3.1K
Filed: Feb 13, 2025

View

Earnings & Events

Earnings Calls

Last call

Aug 7, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
EMBC	+15.4%	+56.9%	-51.8%	+40.1%	-57.1%
SPY	+0.4%	+4.5%	+13.8%	+3.9%	+13.9%
vs SPY	+15.0%	+52.5%	-65.5%	+36.2%	-70.9%

Capital returns

Latest dividend

$0.01 / share · ex May 28, 2026

Declared · upcoming

$0.01 / share · ex Aug 27, 2026

Cut 93.3%

Paid (TTM)

$0.46 / share · 4 payouts

Dividend yield (TTM, derived)

9.02%

Buyback program · as of Aug 7, 2026

Authorized

$100.00M

Spent (derived)

—

Remaining

—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1872789 CUSIP 29082K105 13F (30d) 301 filings 283 filers Visit website Investor relations

EMBC · Embecta Corp.

Price & Indicators

Up next

AI Brief

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns